| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $612K | -80.8% |
| Cost of Revenue | $3K | -99.9% |
| R&D Expense | $51K | -87.7% |
| SG&A Expense | $8.9M | +45.6% |
| Operating Income | -$15.0M | -93.3% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$22.6M | -192.1% |
| Income Tax | $0 | — |
| Net Income | -$22.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $142K | -62.8% |
| Accounts Receivable | $32K | -92.1% |
| Current Assets | $3.2M | +54.6% |
| Total Assets | $7.0M | -33.7% |
| Current Liabilities | $4.4M | -54.2% |
| Long-term Debt | $523K | — |
| Total Liabilities | $4.4M | -54.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.1M | -332.5% |
| Investing Cash Flow | $1.8M | — |
| Financing Cash Flow | $3.9M | +282.5% |
| -239.2% |
| EPS (Diluted) | -$3.82 | +32.3% |
| Stockholders' Equity |
| $2.6M |
| +177.5% |